Cerus Corporation
CERS
#7534
Rank
C$0.74 B
Marketcap
C$3.68
Share price
-2.57%
Change (1 day)
111.00%
Change (1 year)

Earnings for Cerus Corporation (CERS)

Earnings in 2026 (TTM): -C$1.41 Million

According to Cerus Corporation's latest financial reports the company's current earnings are C$0.21 Billion. In 2025 the company made an earning of -C$9.65 Million, an increase over its 2024 earnings that were of -C$16.51 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Cerus Corporation from 1997 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -C$1.41 Million-85.41%
2025 -C$9.65 Million-41.58%
2024 -C$16.51 Million-58.95%
2023 -C$40.2 Million-20.74%
2022 -C$50.72 Million-25.7%
2021 -C$68.26 Million-11.99%
2020 -C$77.56 Million-14%
2019 -C$90.19 Million21.73%
2018 -C$74.09 Million-0.65%
2017 -C$74.57 Million-10.96%
2016 -C$83.76 Million4.24%
2015 -C$80.35 Million50.99%
2014 -C$53.22 Million-10.08%
2013 -C$59.18 Million184.13%
2012 -C$20.83 Million-7.91%
2011 -C$22.62 Million
2009 -C$31.95 Million-24.69%
2008 -C$42.42 Million-25.2%
2007 -C$56.71 Million330.54%
2006 -C$13.17 Million1.49%
2005 -C$12.98 Million-61.02%
2004 -C$33.3 Million
2002 -C$82.35 Million10.02%
2001 -C$74.85 Million34.25%
2000 -C$55.76 Million61.02%
1999 -C$34.63 Million-18.81%
1998 -C$42.65 Million93.08%
1997 -C$22.09 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Boston Scientific
BSX
C$5.19 B-343,088.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Utah Medical Products
UTMD
C$18.66 M-1,331.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Haemonetics
HAE
C$0.21 B-14,466.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
-C$20.73 Million 1,267.28%๐Ÿ‡บ๐Ÿ‡ธ USA